UnitedHealth Group Shares Are on the Move Up

Let's check on the charts and indicators.

Have Patience as NovoCure Looks for a New Bottom Pattern

Let's review the charts and indicators.

The Hammer Bottom Reversal on Sharecare Turned Me Bullish

Here's our price objective for now.

Clinically Speaking: 6 Stocks Behind the Scenes at Drug Trials

Investors are increasingly looking to the companies involved in clinical trials. Here are six favorite names in this space.

Prospective Pickings Are Slim for This Annual Portfolio of Unloved Losers

The current candidates for the 2022 Tax-Loss Selling Recovery Portfolio are few and far between, with only a couple households names in the bunch.

Here's Why Paratek Pharmaceuticals Is the Only Antibiotic Name in My Portfolio

The economics of this space is not nearly as favorable as the outcomes these drugs achieve in medical settings.

3 Smaller Healthcare Stocks That Still Look Like Values in a Pricey Market

ProQR Therapeutics, Oscar Health and Hims & Hers Health appear to have promising futures.

I'm in the Buy and Hold Category With FIGS

FIGS has become the trendy play for scrubs.

A 'Trip' to the Boardroom: A Look at Psychedelic Med's Top Players

To help readers navigate this mushrooming opportunity, I've put together a list of the top corporate leaders in the field.

Biohaven Pharmaceutical Is Ready to Climb Higher on the Charts

Continue to hold previously recommended longs.